SPAG4 promotes survival of cancer cells under hypoxic conditions and leads to poor prognosis of several cancers, including renal cell carcinoma (45), glioblastoma (46), Pancreatic Ductal Adenocarcinoma (47). Here, SPAG4 is linked to renal cell carcinoma.